SCHEMBL8516304

SCHEMBL8516304

CC1Cc2ccccc2N1C=O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOTUM Q6P988 1/20 0.53
ALDH1A1 P00352 5/20 0.46
NPC1 O15118 2/20 0.46
LMNA P02545 3/20 0.45
MEN1 O00255 1/20 0.43
MAPT P10636 1/20 0.43
KMT2A Q03164 1/20 0.43
CHRM2 P08172 1/20 0.43
CHRM4 P08173 1/20 0.43
CHRM1 P11229 1/20 0.43
CHRM3 P20309 1/20 0.43
HTR2A P28223 3/20 0.42
HTR2C P28335 3/20 0.42
HTR2B P41595 3/20 0.42
PKM P14618 1/20 0.42
RAB9A P51151 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
CYP1A2 P05177 1/20 0.42
CYP2C19 P33261 1/20 0.42
SLC22A12 Q96S37 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22018747 0.81 NOTUM (0.49) NOTUMALDH1A1NPC1LMNAMEN1
SCHEMBL11307322 0.81 NOTUM (0.49) NOTUMALDH1A1NPC1LMNAMEN1
SCHEMBL24201529 0.80 NOTUM (0.47) NOTUMALDH1A1NPC1LMNAMEN1
SCHEMBL5218354 0.78 NOTUM (0.41) NOTUMALDH1A1NPC1MEN1KMT2A
SCHEMBL11582790 0.77 DRD2 (0.41) NOTUMALDH1A1NPC1LMNAPKM
SCHEMBL28314815 0.75 NOTUM (0.42) NOTUMNPC1MEN1KMT2ACHRM2
Formamide SCHEMBL4376802 0.75 NOTUM (0.50) NOTUMALDH1A1NPC1LMNAMEN1
SCHEMBL29740237 0.75 NOTUM (0.43) NOTUMALDH1A1NPC1LMNAMEN1
SCHEMBL22292629 0.75 NOTUM (0.53) NOTUMALDH1A1NPC1LMNAMEN1
SCHEMBL1517961 0.74 NOTUM (0.49) NOTUMALDH1A1LMNAMEN1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108774147-B N-aryl formamide prepared by taking bromodifluoroacetic acid ethyl ester as formylation reagent 温州大学 2021-01-08 CN disclosed
CN-108774147-A A kind of N- aryl carboxamides prepared as formylation reagent using bromo difluoro acetate ethyl ester 温州大学 2018-11-09 CN disclosed
US-8759461-B2 Post metallocene-type transition metal compounds LG CHEM, LTD. (KR) 2014-06-24 US disclosed
CN-102548962-B Novel post metallocene-type transition metal compound LG CHEMICAL LTD 2014-06-18 CN disclosed
EP-2457894-B1 NOVEL POST METALLOCENE-TYPE TRANSITION METAL COMPOUND LG CHEMICAL LTD (KR) 2014-01-22 EP disclosed
US-20120196994-A1 NOVEL POST METALLOCENE-TYPE TRANSITION METAL COMPOUNDS LG CHEM, LTD. (KR) 2012-08-02 US disclosed
CN-102548962-A Novel post metallocene-type transition metal compound LG CHEMICAL LTD 2012-07-04 CN disclosed
EP-2457894-A2 NOVEL POST METALLOCENE-TYPE TRANSITION METAL COMPOUND LG Chem, Ltd. (KR) 2012-05-30 EP disclosed
US-5130442-A Compounds for forming color in recording material based on acid developers BAYER AKTIENGESELLSCHAFT (DE) 1992-07-14 US disclosed
EP-0431425-A2 Chromogen enamine compounds, their preparation and use as colour formers BAYER AG (DE) 1991-06-12 EP disclosed
US-4145537-A BENZOTHIAZOLIUM DYES BAYER AKTIENGESELLSCHAFT (DE) 1979-03-20 US disclosed
US-4110070-A QUATERNIZING INDOLENINE METHINE COMPOUND ON FIBERS TO FORM CATIONIC DYE HODOGAYA CHEMICAL CO., LTD. (JP) 1978-08-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120196994-A1 NOVEL POST METALLOCENE-TYPE TRANSITION METAL COMPOUNDS ZC3HAV1L, ZKSCAN2, ZC3H18 NOTUM 638/4885ALDH1A1 3061/4885NPC1 3581/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.